Norkrans G - Search Results

1

Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3.

Rembeck K, Waldenström J, Hellstrand K, Nilsson S, Nyström K, Martner A, Lindh M, Norkrans G, Westin J, Pedersen C, Färkkilä M, Langeland N, Buhl MR, Mørch K, Christensen PB, Lagging M. Rembeck K, et al. Among authors: norkrans g. Hepatology. 2014 Jun;59(6):2131-9. doi: 10.1002/hep.27009. Epub 2014 Apr 25. Hepatology. 2014. PMID: 24519039 Clinical Trial.

2

The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.

Pedersen C, Sandström E, Petersen CS, Norkrans G, Gerstoft J, Karlsson A, Christensen KC, Håkansson C, Pehrson PO, Nielsen JO, et al. Pedersen C, et al. Among authors: norkrans g. N Engl J Med. 1990 Jun 21;322(25):1757-63. doi: 10.1056/NEJM199006213222501. N Engl J Med. 1990. PMID: 1693173 Free article. Clinical Trial.

3

High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks.

Reichard O, Foberg U, Frydén A, Mattsson L, Norkrans G, Sönnerborg A, Wejstål R, Yun ZB, Weiland O. Reichard O, et al. Among authors: norkrans g. Hepatology. 1994 Feb;19(2):280-5. Hepatology. 1994. PMID: 7507462 Clinical Trial.

4

Emergence of precore TAG mutation during hepatitis B e seroconversion and its dependence on pregenomic base pairing between nucleotides 1858 of 1896.

Lindh M, Furuta Y, Vahlne A, Norkrans G, Horal P. Lindh M, et al. Among authors: norkrans g. J Infect Dis. 1995 Nov;172(5):1343-7. doi: 10.1093/infdis/172.5.1343. J Infect Dis. 1995. PMID: 7594674

5

Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment.

Reichard O, Glaumann H, Frydén A, Norkrans G, Schvarcz R, Sönnerborg A, Yun ZB, Weiland O. Reichard O, et al. Among authors: norkrans g. Hepatology. 1995 Apr;21(4):918-22. Hepatology. 1995. PMID: 7705800

6

Detection of hepatitis B virus precore TAG mutant by an amplification-created restriction site method.

Lindh M, Furuta Y, Ljunggren KK, Norkrans G, Horal P. Lindh M, et al. Among authors: norkrans g. J Infect Dis. 1995 Jan;171(1):194-7. doi: 10.1093/infdis/171.1.194. J Infect Dis. 1995. PMID: 7798663

7

Hepatitis B carriers in Sweden--effects of immigration.

Lindh M, Norkrans G, Stenqvist K, Eriksson K, Taranger J. Lindh M, et al. Among authors: norkrans g. Scand J Infect Dis. 1993;25(4):411-6. doi: 10.3109/00365549309008520. Scand J Infect Dis. 1993. PMID: 8248739

8

Hepatitis B virus carriers without precore mutations in hepatitis B e antigen-negative stage show more severe liver damage.

Lindh M, Horal P, Dhillon AP, Furuta Y, Norkrans G. Lindh M, et al. Among authors: norkrans g. Hepatology. 1996 Sep;24(3):494-501. doi: 10.1002/hep.510240305. Hepatology. 1996. PMID: 8781313

9

The importance of cofactors in the histologic progression of minimal and mild chronic hepatitis C.

Shev S, Dhillon AP, Lindh M, Serléus Z, Wejstål R, Widell A, Norkrans G. Shev S, et al. Among authors: norkrans g. Liver. 1997 Oct;17(5):215-23. doi: 10.1111/j.1600-0676.1997.tb01021.x. Liver. 1997. PMID: 9387912

10

Histamine and the response to IFN-alpha in chronic hepatitis C.

Hellstrand K, Brune M, Mellqvist UH, Norkrans G, Lundberg PA, Hermodsson S, Wejstål R. Hellstrand K, et al. Among authors: norkrans g. J Interferon Cytokine Res. 1998 Jan;18(1):21-2. doi: 10.1089/jir.1998.18.21. J Interferon Cytokine Res. 1998. PMID: 9475663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page